An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 204, Issue 5, Pages 1111-1118
Publisher
The American Association of Immunologists
Online
2020-01-21
DOI
10.4049/jimmunol.1901166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
- (2019) Carla M. Startin et al. Alzheimers Research & Therapy
- Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer’s Disease and in Down Syndrome Dementia
- (2019) Ruma Raha-Chowdhury et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
- (2019) Michael Ewers et al. Science Translational Medicine
- Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer’s Disease Pathology in Down Syndrome
- (2018) Ruma Raha-Chowdhury et al. JOURNAL OF ALZHEIMERS DISEASE
- Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease
- (2018) L.M. Bekris et al. JOURNAL OF NEUROIMMUNOLOGY
- Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome
- (2018) Eleonore Bayen et al. JAMA Neurology
- Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
- (2018) Juan Fortea et al. LANCET NEUROLOGY
- Soluble TREM2 changes during the clinical course of Alzheimer’s disease: A meta-analysis
- (2018) Dan Liu et al. NEUROSCIENCE LETTERS
- CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
- (2018) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)
- (2017) Michael S. Rafii et al. JOURNAL OF ALZHEIMERS DISEASE
- Exposure to gestational diabetes mellitus induces neuroinflammation, derangement of hippocampal neurons, and cognitive changes in rat offspring
- (2017) Billy Vuong et al. Journal of Neuroinflammation
- Altered peripheral profile of blood cells in Alzheimer disease
- (2017) Si-Han Chen et al. MEDICINE
- Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis
- (2017) Yan Zhang et al. Oncotarget
- Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation
- (2017) Kelly D. Sullivan et al. Scientific Reports
- Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer’s Disease
- (2017) Ni-Chung Lee et al. Frontiers in Aging Neuroscience
- Multiple SNPs Within and Surrounding the Apolipoprotein E Gene Influence Cerebrospinal Fluid Apolipoprotein E Protein Levels
- (2017) Lynn M. Bekris et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased levels of plasma total tau in adult Down syndrome
- (2017) Takashi Kasai et al. PLoS One
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease
- (2016) Juan Domingo Gispert et al. Alzheimers & Dementia
- An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation
- (2016) M. Florencia Iulita et al. Alzheimers & Dementia
- Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients
- (2016) Shu Yu et al. CLINICA CHIMICA ACTA
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review
- (2016) Maryam Boshtam et al. INFLAMMATION
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury
- (2016) M. Suarez-Calvet et al. Science Translational Medicine
- Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
- (2016) Kristi Henjum et al. Alzheimers Research & Therapy
- Haematopoietic development and leukaemia in Down syndrome
- (2014) Irene Roberts et al. BRITISH JOURNAL OF HAEMATOLOGY
- IL-6 Strikes a Balance in Metabolic Inflammation
- (2014) Anthony J. Covarrubias et al. Cell Metabolism
- Altered Expression of Immune-Related Genes in Children with Down Syndrome
- (2014) Bruna Lancia Zampieri et al. PLoS One
- Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
- (2013) Donna M Wilcock et al. Journal of Neuroinflammation
- The National Task Group on Intellectual Disabilities and Dementia Practices Consensus Recommendations for the Evaluation and Management of Dementia in Adults With Intellectual Disabilities
- (2013) Julie A. Moran et al. MAYO CLINIC PROCEEDINGS
- TREM2 and Neurodegenerative Disease
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Peripheral markers of Alzheimer's disease: Surveillance of white blood cells
- (2013) Kaneez Fatima Shad et al. SYNAPSE
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
- (2011) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Inflammatory and Immunological parameters in adults with Down syndrome
- (2011) Maria BF Trotta et al. Immunity & Ageing
- The Spectrum of Mutations in Progranulin
- (2010) Chang-En Yu et al. ARCHIVES OF NEUROLOGY
- The multifaceted effects of granulocyte colony-stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis
- (2010) Andrew Martins et al. IUBMB LIFE
- Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
- (2009) Satish L. Deshmane et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and β-catenin
- (2009) Karel Otero et al. NATURE IMMUNOLOGY
- Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease
- (2008) Peder Buchhave et al. NEUROSCIENCE LETTERS
- Enhanced soluble CD40 ligand and Alzheimer's disease: Evidence of a possible pathogenetic role
- (2006) Giovambattista Desideri et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now